| 000 | 01761 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517061054.0 | ||
| 264 | 0 | _c20160808 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1791-2431 | ||
| 024 | 7 |
_a10.3892/or.2015.4324 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHung, Ming-Szu | |
| 245 | 0 | 0 |
_aKnockdown of Cul4A increases chemosensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells. _h[electronic resource] |
| 260 |
_bOncology reports _cDec 2015 |
||
| 300 |
_a3187-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xgenetics |
| 650 | 0 | 4 |
_aCullin Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 |
_aExtracellular Matrix Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aGene Knockdown Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xbiosynthesis |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aChen, I-Chuan | |
| 700 | 1 | _aYou, Liang | |
| 700 | 1 | _aJablons, David M | |
| 700 | 1 | _aLi, Ya-Chin | |
| 700 | 1 | _aMao, Jian-Hua | |
| 700 | 1 | _aXu, Zhidong | |
| 700 | 1 | _aHsieh, Meng-Jer | |
| 700 | 1 | _aLin, Yu-Ching | |
| 700 | 1 | _aYang, Cheng-Ta | |
| 700 | 1 | _aLiu, Shin-Tung | |
| 700 | 1 | _aTsai, Ying-Huang | |
| 773 | 0 |
_tOncology reports _gvol. 34 _gno. 6 _gp. 3187-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/or.2015.4324 _zAvailable from publisher's website |
| 999 |
_c25389625 _d25389625 |
||